COURAGE Suggests Stents Do Not Benefit Stable Coronary Disease Patients
This article was originally published in The Gray Sheet
Executive Summary
Results of the highly anticipated COURAGE trial challenge the widespread assumption that stents improve outcomes in patients with stable coronary disease, but several observers believe the findings' impact on the stent market will be modest